NLRP1 protein inhibitor (Odyssey Therapeutics)

N/A

Report date: 2025/03/13 16:56:00
NME

Base Information

Drug NameNLRP1 protein inhibitor (Odyssey Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 1 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 1
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIFM Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOdyssey Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A